SloveniaThe article discusses the challenges faced by children suffering from rare diseases in Slovenia, highlighting how their access to life-saving treatments often depends on media pressure, lobbying by non-governmental organizations, and bureaucratic hurdles rather than medical expertise. It criticizes the Slovenian healthcare system for turning into a bureaucratic machine that prioritizes paperwork over patient care. The European Union has established regulations for orphan drugs, which are intended to provide significant benefits to patients with rare conditions, but these have been rigidly interpreted by Slovenian authorities, leading to delays in treatment approval. The article uses the case of a child named Urban, who received groundbreaking gene therapy for a rare genetic disorder, to illustrate the human cost of these administrative barriers.
Bias read (Progressive): The article frames the issue of rare disease treatment through a critical lens of the Slovenian bureaucracy and healthcare system, emphasizing systemic failures and the lack of support for vulnerable patients. It uses emotionally charged language such as 'zlobo države' ('state cruelty') and 'birokr茨
